Virtual Reality for ICU Delirium Prevention
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Cedars-Sinai Medical Center
- Study ID
- NCT07357389
- Status
- Recruiting
Conditions
- ICU Delirium
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Virtual Reality therapeutics — DEVICEPatients will receive daily VR sessions for up to 5 days in addition to regular delirium prevention measures in the ICU
Study Details
The purpose of this study is to evaluate whether daily exposure to immersive virtual reality (VR) can reduce the incidence of delirium in high-risk, non-intubated ICU patients. Participants will be randomized to either standard ICU care or standard care plus once-daily 15-minute VR sessions consisting of calming natural scenes, guided meditation, and music. The study population includes adult surgical ICU patients at Cedars-Sinai who are CAM-ICU negative at enrollment and possess at least one established risk factor for delirium. Outcomes will include the incidence and duration of delirium, ICU and hospital length of stay, feasibility of the VR intervention, and the frequency of adverse events. By targeting a high-risk population with an innovative non-pharmacologic therapy, this trial aims to generate data to support integration of VR into ICU delirium prevention protocols.
Key Dates
- Start date
- Mar 10, 2026
- Status verified
- Jan 2026
- Primary completion
- Jan 15, 2028
- Completion
- Apr 30, 2028
Study Design
- Enrollment
- 822 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- No Intervention: Standard ICU delirium prevention
- Experimental: Study ICU Delirium Prevention and VR treatment
Primary Outcome Measure
Incidence of ICU Delirium [ Time Frame: From enrollment in the study until ICU discharge. Assessed Day 1 in the morning and evening for the duration of the ICU admission, up to 24 months from enrollment. ]
Central Contacts
- Devon S Callahan, MD310-423-2402
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars Sinai Medical Center | Los Angeles | California | 90048 |
Find similar trials in Los Angeles, CA
Related Studies
- Exogenous Ketone Supplementation in ICU DeliriumPHASE1 · Recruiting · Vanderbilt University Medical Center · Nashville, Tennessee